OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

Rhea-AI Summary

OraSure Technologies (NASDAQ: OSUR) has announced it will release its first quarter 2025 financial results on May 7th, 2025 at 5 p.m. ET. The company will host an earnings conference call to discuss Q1 2025 results and business developments.

A webcast of the conference call will be accessible through OraSure's investor relations website. The webcast recording will remain available for approximately one year after the call. Participants wishing to ask questions during the call must pre-register through the provided registration link.

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025.

A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately one year.

For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.

https://register-conf.media-server.com/register/BI59f66a2310854c78a00d41966823f810

About OraSure Technologies, Inc. 
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com

Investor Contact:	Media Contact:
Jason Plagman	Amy Koch
VP, Investor Relations	Director, Corporate Communications
investorinfo@orasure.com	media@orasure.com

FAQ

When will OraSure (OSUR) report Q1 2025 earnings?

OraSure Technologies will report its Q1 2025 earnings on May 7th, 2025 at 5:00 PM Eastern Time.

How can investors access OraSure's Q1 2025 earnings call?

Investors can access the earnings call through the webcast link on OraSure's investor relations website at orasure.gcs-web.com/events-and-presentations.

How long will OraSure's Q1 2025 earnings webcast be available?

The webcast will be archived on OraSure's website for approximately one year after the call.

Do investors need to register to ask questions during OraSure's Q1 earnings call?

Yes, participants who wish to ask questions during the call must pre-register through the provided registration link.